NanoPhoria Bioscience, a next-generation biotech developing inhalable cardiovascular therapies, has raised €83.5 million in a landmark Series A round — the largest ever for an Italian biotech.
Copyright © 2023. Founders Today. All rights reserved
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?